---
title: "TEM: $1.5B acquisition combines MRD portfolios to drive growth, data synergies, and profitability by 2027"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293238275.md"
description: "The acquisition will combine complementary MRD assay portfolios, accelerate commercial adoption, and enhance data-driven insights for biopharma clients. The $1.5B all-stock deal is timed as Personalis' financials improve, with integration and expanded reimbursement expected to drive growth and profitability by 2027.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-20T16:20:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293238275.md)
  - [en](https://longbridge.com/en/news/293238275.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293238275.md)
---

# TEM: $1.5B acquisition combines MRD portfolios to drive growth, data synergies, and profitability by 2027

The acquisition will combine complementary MRD assay portfolios, accelerate commercial adoption, and enhance data-driven insights for biopharma clients. The $1.5B all-stock deal is timed as Personalis' financials improve, with integration and expanded reimbursement expected to drive growth and profitability by 2027.

Based on

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [PSNL.US](https://longbridge.com/en/quote/PSNL.US.md)
- [TEM.US](https://longbridge.com/en/quote/TEM.US.md)
- [TEMT.US](https://longbridge.com/en/quote/TEMT.US.md)

## Related News & Research

- [Tempus AI CEO Data Ryan Fukushima disposes of 20.000 shares worth $1 juta](https://longbridge.com/en/news/295583550.md)
- [TEM: Q2 2026 delivered 22% revenue growth, net income turnaround, and major MRD expansion via acquisition](https://longbridge.com/en/news/294408929.md)
- [TEM: A $1.5B acquisition merges AI oncology and MRD tech to lead in cancer monitoring](https://longbridge.com/en/news/293215484.md)
- [Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells $1,000,800.00 in Stock](https://longbridge.com/en/news/295641043.md)
- [Tech innovator uses AI to rebuild David Webb’s Hong Kong database](https://longbridge.com/en/news/295659306.md)